GENE ONLINE|News &
Syndax Pharmaceuticals to Announce Q1 2026 Financial Results on April 30
Syndax Pharmaceuticals has scheduled the release of its financial results for the first quarter of 2026. The company plans to announce the earnings on April 30, 2026, and will host a conference call and webcast on the same day to discuss the details.
The announcement will provide an overview of Syndax’s financial performance for the quarter ending March 31, 2026. The conference call and webcast are expected to include insights from company executives regarding recent developments, operational highlights, and future outlooks. Interested parties can access further information through Syndax’s official communication channels.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: April 24, 2026
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
LATEST
Digitalis Glycosides Studied for Heart Failure Treatment at ESC Heart Failure 2026 Congress
2026-05-10
Digoxin Lowers Death Risk and Heart Failure in Rheumatic Heart Disease Patients, Study Finds
2026-05-10
New Test Detects Biomarkers for Frontotemporal Lobar Degeneration, a Rare Dementia Affecting Over 57 Million Globally
2026-05-10
